Protagenic Therapeutics Inc (PTIX)
1.29
+0.05
(+3.95%)
USD |
NASDAQ |
May 09, 16:00
1.28
-0.01
(-0.78%)
After-Hours: 20:00
Protagenic Therapeutics Cash from Financing (TTM)
Cash from Financing (TTM) Chart
Historical Cash from Financing (TTM) Data
| Date | Value |
|---|---|
| December 31, 2021 | 12.58M |
| September 30, 2021 | 12.58M |
| June 30, 2021 | 12.90M |
| March 31, 2021 | 1.020M |
| December 31, 2020 | 1.223M |
| September 30, 2020 | 1.893M |
| June 30, 2020 | 1.57M |
| March 31, 2020 | 1.00M |
| December 31, 2019 | 0.67M |
| September 30, 2019 | |
| June 30, 2019 | |
| March 31, 2019 | |
| December 31, 2018 | |
| September 30, 2018 | |
| June 30, 2018 | |
| March 31, 2018 | |
| December 31, 2017 | |
| September 30, 2017 | |
| June 30, 2017 | |
| March 31, 2017 | |
| December 31, 2016 | 4.284M |
| September 30, 2016 | 4.402M |
| June 30, 2016 | 4.452M |
| March 31, 2016 | 4.047M |
| December 31, 2015 | 0.25M |
| Date | Value |
|---|---|
| September 30, 2015 | 0.30M |
| June 30, 2015 | 0.34M |
| March 31, 2015 | 0.24M |
| December 31, 2014 | 0.415M |
| September 30, 2014 | 0.265M |
| June 30, 2014 | 0.175M |
| March 31, 2014 | 0.173M |
| December 31, 2013 | 4.303M |
| September 30, 2013 | 4.359M |
| September 30, 2011 | 4.359M |
| June 30, 2011 | 4.361M |
| March 31, 2011 | 0.047M |
| December 31, 2010 | -0.009M |
| September 30, 2010 | -0.009M |
| June 30, 2010 | 0.129M |
| March 31, 2010 | -1.88M |
| December 31, 2009 | -2.839M |
| September 30, 2009 | -3.294M |
| June 30, 2009 | -4.93M |
| March 31, 2009 | -3.628M |
| December 31, 2008 | -2.804M |
| September 30, 2008 | -2.36M |
| June 30, 2008 | -0.895M |
| March 31, 2008 | -0.308M |
| December 31, 2007 | 17.46M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (TTM) Range, Past 5 Years
0.67M
Minimum
Dec 2019
12.90M
Maximum
Jun 2021
5.048M
Average
1.57M
Median
Jun 2020
Cash from Financing (TTM) Benchmarks
| Ekso Bionics Holdings Inc | -- |
| Eyenovia Inc | 19.79M |
| Palisade Bio Inc | 11.19M |
| NovaBay Pharmaceuticals Inc | 1.91M |
| Palatin Technologies Inc | 5.553M |